盈康生命: 关于收购长沙珂信肿瘤医院有限公司51%股权的进展公告

Transaction Overview - The company has approved the acquisition of 51% equity in Changsha Kexin Tumor Hospital Co., Ltd. for a total amount of RMB 357 million [1] - The valuation for the equity transfer was based on an asset evaluation report from Shanghai Dongzhou Asset Appraisal Co., Ltd. [1] Progress Update - All parties involved have confirmed the completion of pre-delivery obligations as per the equity transfer agreement [2] - The company has made the initial payment for the equity transfer to Hunan Kexin Health Industry Group Co., Ltd. [2] - The equity transfer has been officially registered, and the business license for Changsha Kexin has been updated [2] Changes in Business Registration - After the completion of the business registration change, the company now holds 51% of Changsha Kexin, making it a subsidiary included in the company's consolidated financial statements [2] - The updated shareholding structure shows the company holding 51% and Kexin Group holding 49% [2]